Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3958875
Max Phase: Preclinical
Molecular Formula: C22H24N2O3
Molecular Weight: 364.45
Molecule Type: Small molecule
Associated Items:
ID: ALA3958875
Max Phase: Preclinical
Molecular Formula: C22H24N2O3
Molecular Weight: 364.45
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCC[C@H]1C/C(=N/OCc2ccccc2)C[C@]2(O1)C(=O)Nc1ccccc12
Standard InChI: InChI=1S/C22H24N2O3/c1-2-8-18-13-17(24-26-15-16-9-4-3-5-10-16)14-22(27-18)19-11-6-7-12-20(19)23-21(22)25/h3-7,9-12,18H,2,8,13-15H2,1H3,(H,23,25)/b24-17-/t18-,22+/m0/s1
Standard InChI Key: PVYMEAANGXOWGU-QDZUZFBZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 364.45 | Molecular Weight (Monoisotopic): 364.1787 | AlogP: 4.39 | #Rotatable Bonds: 5 |
Polar Surface Area: 59.92 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.03 | CX Basic pKa: 2.82 | CX LogP: 4.55 | CX LogD: 4.55 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.80 | Np Likeness Score: 0.31 |
1. Kobayashi K, Ohshiro T, Tomoda H, Yin F, Cui HL, Chouthaiwale PV, Tanaka F.. (2016) Discovery of SOAT2 inhibitors from synthetic small molecules., 26 (24): [PMID:27876317] [10.1016/j.bmcl.2016.11.008] |
Source(1):